IRIS
BRAIDO, FULVIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 21.959
AS - Asia 27
SA - Sud America 13
NA - Nord America 2
Totale 22.001
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 21.956
CN - Cina 18
BR - Brasile 9
VN - Vietnam 5
SG - Singapore 4
AR - Argentina 2
US - Stati Uniti d'America 2
AT - Austria 1
BA - Bosnia-Erzegovina 1
CL - Cile 1
PY - Paraguay 1
SE - Svezia 1
Totale 22.001
Salva come PNG Salva come JPEG
Città #
Genova 13.147
Genoa 5.452
Rapallo 1.871
Vado Ligure 1.422
Bordighera 63
Beijing 6
Ho Chi Minh City 4
Singapore 4
Ashburn 2
Ribeirão Preto 2
Aracaju 1
Asunción 1
Camaçari 1
Corrientes 1
Guarulhos 1
Ha Long 1
Las Condes 1
Paulo Afonso 1
Quilmes 1
Santa Rosa de Viterbo 1
Tomislavgrad 1
Turin 1
Vargem Grande Paulista 1
Vienna 1
Volta Redonda 1
Totale 21.988
Salva come PNG Salva come JPEG
Nome #
Clinical characteristics, management and in-hospital mortality of patients with COVID-19 In Genoa, Italy 258
RAPP-children: A new tool for assessing quality of life in patients with asthma and rhinitis 255
null 200
Administration of a polyvalent mechanical bacterial lysate to elderly patients with COPD: Effects on circulating T, B and NK cells. 188
The perception of Obstructive Sleep Apnoea/Hypopnoea Syndrome (OSAHS) among Italian general practitioners 181
'Emergency exit' of bone-marrow-resident CD34+ DNAM-1 bright CXCR4+-committed lymphoid precursors during chronic infection and inflammation 174
Exploring the Relationship between Disease Awareness and Outcomes in Patients with Chronic Obstructive Pulmonary Disease 171
A new tool to assess and monitor the burden of chronic cough on quality of life: Chronic Cough Impact Questionnaire. 166
The administration of a polyvalent mechanical bacterial lysate in elderly patients with COPD results in serological signs of an efficient immune response associated with a reduced number of acute episodes 162
Antiallergic drugs and quality of life. 159
Allergic diseases and their impact on quality of life. 155
Genuair® Usability Test: Results of a National Public Survey of the Elderly 155
Prevalence and prognostic value of cardiac troponin in elderly patients hospitalized for COVID-19 153
COPD treatment: Real life and experimental effects on peripheral NK cells, their receptors expression and their IFN-γ secretion. 152
The bacterial lysate Lantigen B reduces the number of acute episodes in patients with recurrent infections of the respiratory tract: the results of a double blind, placebo controlled, multicenter clinical trial 152
An update on allergen immunotherapy and asthma 151
CD4+CD25highCD127- regulatory T-cells in COPD: Smoke and drugs effect 150
A new tool to evaluate the impact of chronic urticaria on quality of life: chronic urticaria quality of life questionnaire (CU-QoL). 149
Allergic rhinitis and asthma ad hoc survey: clinical and psychological perspectives. 149
Sleep complaints and sleep breathing disorders in upper and lower obstructive lung diseases 149
Patients beliefs on intravenous and subcutaneous routes of administration of biologics for severe asthma treatment: A cross-sectional observational survey study 148
Recommendations for assessing patient-reported outcomes and health-related quality of life in patients with urticaria: a GA(2) LEN taskforce position paper. 146
Clara cell 16 protein in COPD sputum: A marker of small airways damage? 145
RhinAsthma patient perspective: A Rasch validation study 145
Basi Patogenetiche ed anatomopatologiche della flogosi allergica nell’asma bronchiale 144
Chronic Urticaria Patient Perspective (CUPP): The First Validated Tool for Assessing Quality of Life in Clinical Practice 144
Clinical and Functional Characteristics of COPD Patients Across GOLD Classifications: Results of a Multicenter Observational Study 144
Viruses and bacteria in acute asthma exacerbations--a GA² LEN-DARE systematic review. 143
The relationship between allergen immunotherapy and omalizumab for treating asthma 143
"Trying, But Failing" - The Role of Inhaler Technique and Mode of Delivery in Respiratory Medication Adherence 143
Sub-lingual administration of a polyvalent mechanical bacterial lysate (PMBL) in patients with moderate, severe, or very severe chronic obstructive pulmonary disease (COPD) according to the GOLD spirometric classification: A multicentre, double-blind, randomised, controlled, phase IV study (AIACE study: Advanced Immunological Approach in COPD Exacerbation) 141
Patient-physician relationship in the management of asthma: Multicentric approach in Latin America 141
Determinants and impact of suboptimal asthma control in Europe: The INTERNATIONAL CROSS-SECTIONAL AND LONGITUDINAL ASSESSMENT ON ASTHMA CONTROL (LIAISON) study 138
Why use long acting bronchodilators in chronic obstructive lung diseases? An extensive review on formoterol and salmeterol 138
Biosimilars in allergic diseases 138
InternationaL cross-sectIonAl and longItudinal assessment on aSthma cONtrol in European adult patients--the LIAISON study protocol. 136
Illness perception, mood and coping strategies in allergic rhinitis: are there differences among ARIA classes of severity? 136
Manifesto on small airway involvement and management in asthma and chronic obstructive pulmonary disease: an Interasma (Global Asthma Association - GAA) and World Allergy Organization (WAO) document endorsed by Allergic Rhinitis and its Impact on Asthma (ARIA) and Global Allergy and Asthma European Network (GA2LEN) 136
Umeclidinium for the treatment of uncontrolled asthma 136
The unmet need for pertussis prevention in patients with chronic obstructive pulmonary disease in the Italian context 136
The Portuguese version of Rhinitis and Asthma Patient's Perspective (RAPP): Validation and assessment 136
Which factors affect the choice of the inhaler in chronic obstructive respiratory diseases? 135
Pidotimod: The state of art 134
Asthma management in a specialist setting: Results of an Italian Respiratory Society survey 134
Clinical characteristics, management and in-hospital mortality of patients with coronavirus disease 2019 in Genoa, Italy 134
Coping with asthma: is the physician able to identify patient's behaviour? 133
Pitfalls in respiratory allergy management: alexithymia and its impact on patient-reported outcomes. 133
Adherence to treatment: assessment of an unmet need in asthma. 132
Adherence to asthma treatments: 'We know, we intend, we advocate' 132
Minimal clinical important difference (MCID) of the Thai chronic urticaria quality of life questionnaire (CU-Q2oL) 131
Why do doctors and patients not follow guidelines? 130
Randomized controlled trials and real life studies. Approaches and methodologies: A clinical point of view 130
Patient-reported outcomes in asthma clinical trials 130
Disease awareness in patients with COPD: measurement and extent 129
RHINASTHMA-Adolescents: a new quality of life tool for patients with respiratory allergy 129
Recommendations for assessing patient-reported outcomes and health-related quality of life in clinical trials on allergy: a GA(2)LEN taskforce position paper. 128
Long-acting bronchodilators improve health related quality of life in patients with COPD. 128
New therapies for allergic rhinitis 128
Minimal important difference of the Chronic Urticaria Quality of Life Questionnaire (CU-Q2oL) 128
New treatment options in allergic rhinitis: patient considerations and the role of ciclesonide. 128
Effects of mometasone furoate on the quality of life: a randomized placebo-controlled trial in persistent allergic rhinitis and intermittent asthma using the Rhinasthma questionnaire. 127
Quality-of-life issues in survivors to anaphylactic reactions to drugs 127
The impact of GINA suggested drugs for the treatment of asthma on Health-Related Quality of Life: a GA(2)LEN review. 127
ARIA 2016: Care pathways implementing emerging technologies for predictive medicine in rhinitis and asthma across the life cycle 126
The ARGA study with general practitioners: Impact of medical education on asthma/rhinitis management 126
Asthma treatment: 'magic bullets which seek their own targets'. 126
Does asthma control correlate with quality of life related to upper and lower airways? A real life study. 124
From "blockbusters" to "biosimilars": An opportunity for patients, medical specialists and health care providers 124
Continuing Medical Education:an international reality 124
Asthma management failure: a flaw in physicians' behavior or in patients' knowledge? 124
Non-invasive ventilation in acute respiratory failure of patients with obesity hypoventilation syndrome 124
A Framework For Step Down Or Therapeutic Re-Organization For Withdrawal Of Inhaled Corticosteroids In Selected Patients With COPD: A Proposal For COPD Management 123
Worldwide differences on the concept of control of asthma. 122
Phenotypes/endotypes-driven treatment in asthma 122
Impact of asthma and comorbid allergic rhinitis on quality of life and control in patients of italian general practitioners 122
Rhinasthma: a new specific QoL questionnaire for patients with rhinitis and asthma. 121
Quality of life and patients' satisfaction in chronic urticaria and respiratory allergy. 121
Cost-description and multiple imputation of missing values: the SATisfaction and adherence to COPD treatment (SAT) study 121
Disability in moderate chronic obstructive pulmonary disease: Prevalence, burden and assessment-results from a real-life study 121
Systematic review on the efficacy of fexofenadine in seasonal allergic rhinitis: a meta-analysis of randomized, double-blind, placebo-controlled clinical trials. 120
Asthma and COPD: Interchangeable use of inhalers. A document of Italian Society of Allergy, Asthma and Clinical Immmunology (SIAAIC) & Italian Society of Respiratory Medicine (SIMeR) 120
Allergic Rhinitis and its Impact on Asthma (ARIA): achievements in 10 years and future needs. 120
MACVIA-ARIA Sentinel NetworK for allergic rhinitis (MASK-rhinitis): The new generation guideline implementation 120
Sleep disturbances in allergic diseases. 119
Quality of life in Duchenne muscular dystrophy: the subjective impact on children and parents. 118
Disease activity only moderately correlates with quality of life impairment in patients with chronic spontaneous urticaria 117
The link between allergic rhinitis and asthma: the united airways disease. 116
ARIA-suggested drugs for allergic rhinitis: what impact on quality of life? A GA2LEN review. 116
Development and validation of the Drug Hypersensitivity Quality of Life Questionnaire. 116
Extensive activation, tissue trafficking, turnover and functional impairment of NK cells in COVID-19 patients at disease onset associates with subsequent disease severity 116
“ Immunologia dell’apparato Respiratorio e metodiche di studio “ Cap 8 115
Obstructive lung diseases and inhaler treatment: results from a national public pragmatic survey. 115
The anti-inflammatory properties of tiotropium 115
Does a low-density gas mixture or oxygen supplementation improve exercise training in COPD? 114
Allergic rhinitis in asthma. 114
Chronic obstructive pulmonary disease patient well-being and its relationship with clinical and patient-reported outcomes: a real-life observational study. 114
Guidance to 2018 good practice: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma 114
Targeted therapy for allergic asthma: predicting and evaluating response to omalizumab. 113
The relationship between asthma control and quality-of-life impairment due to chronic cough: a real-life study. 113
Specific recommendations for PROs and HRQoL assessment in allergic rhinitis and/or asthma: a GA(2)LEN taskforce position paper. 113
Totale 13.662
Salva come PNG Salva come JPEG
Categoria #
all - tutte 77.406
article - articoli 76.691
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 715
Totale 154.812
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.415 0 0 0 235 115 127 127 174 124 200 150 163
2021/20222.437 127 164 117 243 52 250 119 570 182 213 106 294
2022/20232.276 249 118 21 236 326 413 52 181 395 55 184 46
2023/20241.097 61 161 24 115 98 167 90 79 57 28 96 121
2024/20253.448 45 264 131 223 486 375 328 486 184 213 343 370
2025/20262.134 735 195 838 366 0 0 0 0 0 0 0 0
Totale 22.693